Aller au contenu principal
Accès ouvert déclaré 2024 preprint

Policies, practices, opportunities, and challenges for TB screening – A survey of sixty National TB Programmes

0Citations signalées, ce qui n’est pas une note de qualité
7Institutions déclarées
3Pays d’affiliation déclarés

Rattachement africain : gb, ch, Afrique du Sud. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Background To meet incidence reduction goals, the Global Plan to End TB 2023-30 emphasises for the first time that detection of subclinical TB is a priority. WHO Systematic Screening guidelines (2021) have stressed the importance of CXR as a screening tool to achieve this including recommending the use of Computer Aided Detection (CAD) technology. Methods We conducted a cross-sectional survey of National TB Programmes who reported >1000 TB cases annually. The questions aligned with 2021 WHO screening guidelines and aimed to understand country’s practices, policies, and challenges when screening for TB disease. Results Sixty of 123 invited countries responded representing 82% of the global TB burden. Only 66% carried out all 6 WHO-recommended steps to implement screening and 39% collected all 7 of the WHO-recommended datapoints for monitoring activity. Although most countries had a policy for using CXR and increasing CXR-based screening (77% and 68% respectively), 90% reported at least one significant barrier to implementing this and 92% reported at least one barrier to implementing CAD technology. Conclusion Many countries do not carry out all recommended steps for implementation and monitoring of TB screening and although CXR and CAD use are expanding and hold promise as tools to find people with TB, many programmes do not have adequate access to them. While global policy is in place that recommends the use of these tools more efforts should be made to support countries in tackling the barriers that prohibit implementation to make sure that we can close the TB case finding gap. What is already known on this topic Since the publication of the updated WHO TB screening guidelines there are limited published data on how countries carry out screening for TB disease and what the perceived challenges are for implementing screening from a country perspective. What this study adds This study provides data on current and planned screening practices and policies within countries as well as the common challenges being faced to implement screening effectively. How this study might affect research, practice, or policy This information will help developers, policymakers, funding agencies, and academics to better plan and support the roll-out of appropriate screening interventions.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Policies, practices, opportunities, and challenges for TB screening – A survey of sixty National TB Programmes
Date Crossref
05/07/2024
Éditeur
openRxiv
Type
posted-content

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • MRC Clinical Trials Unit at UCL pays non établi dans la notice
    Structure de recherche
  • University College London Institute for Global Health pays non établi dans la notice
    Université ou école supérieure
  • World Health Organization pays non établi dans la notice
    Organisme public
  • University of Cape Town Institute of Infectious Disease and Molecular Medicine University of Cape Town, Afrique du Sud (code pays fourni par la source)
    Université ou école supérieure
  • Wellcome Centre for Infectious Diseases Research in Africa Afrique du Sud (code pays fourni par la source)
    Structure de recherche
  • Institute of Infectious Disease and Molecular Medicine Afrique du Sud (code pays fourni par la source)
    Université ou école supérieure
  • FIND pays non établi dans la notice
    Organisation à but non lucratif
  • Global TB Programme pays non établi dans la notice
    Institution

MRC Clinical Trials Unit at UCL, Institute for Global Health — University College London et World Health Organization, avec 5 autres affiliations. Pays d’affiliation : Afrique du Sud.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Tuberculosis Research and EpidemiologyChronic Disease Management Strategies

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.